verapamil has been researched along with Agammaglobulinemia in 1 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"We report a case of fulminating systemic capillary leak syndrome which temporarily responded to verapamil, a calcium channel blocker." | 3.69 | Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia. ( Hays, RM; Kang, PM; Khan, GA; Lawrence, C, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, PM | 1 |
Lawrence, C | 1 |
Khan, GA | 1 |
Hays, RM | 1 |
1 other study available for verapamil and Agammaglobulinemia
Article | Year |
---|---|
Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia.
Topics: Agammaglobulinemia; Calcium Channel Blockers; Capillary Permeability; Humans; Lymphocytosis; Male; M | 1995 |